Marianne P. Allen

Array ( [id] => 281497 [patent_doc_number] => 07553496 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-30 [patent_title] => 'VEGF-A as an inhibitor of angiogenesis and methods of using same' [patent_app_type] => utility [patent_app_number] => 11/017201 [patent_app_country] => US [patent_app_date] => 2004-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 43 [patent_no_of_words] => 20390 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/553/07553496.pdf [firstpage_image] =>[orig_patent_app_number] => 11017201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9254140 [patent_doc_number] => 08617550 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-31 [patent_title] => 'Treatment of vasculitis with IL-6 antagonist' [patent_app_type] => utility [patent_app_number] => 10/596429 [patent_app_country] => US [patent_app_date] => 2004-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12033 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10596429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 84075 [patent_doc_number] => 07741452 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-22 [patent_title] => 'Glycosylation-deficient hepatocyte growth factor' [patent_app_type] => utility [patent_app_number] => 10/582973 [patent_app_country] => US [patent_app_date] => 2004-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9822 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/741/07741452.pdf [firstpage_image] =>[orig_patent_app_number] => 10582973 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7020018 [patent_doc_number] => 20050222037 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Compounds and methods for modulating VE-cadherin-mediated function' [patent_app_type] => utility [patent_app_number] => 11/004763 [patent_app_country] => US [patent_app_date] => 2004-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 24666 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20050222037.pdf [firstpage_image] =>[orig_patent_app_number] => 11004763 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6959218 [patent_doc_number] => 20050215482 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'Compounds and methods for modulating OB-cadherin-mediated function' [patent_app_type] => utility [patent_app_number] => 11/003150 [patent_app_country] => US [patent_app_date] => 2004-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 27974 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20050215482.pdf [firstpage_image] =>[orig_patent_app_number] => 11003150 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7172051 [patent_doc_number] => 20050203025 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-15 [patent_title] => 'Compounds and methods for modulating nonclassical cadherin-mediated functions' [patent_app_type] => utility [patent_app_number] => 11/004107 [patent_app_country] => US [patent_app_date] => 2004-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 67845 [patent_no_of_claims] => 153 [patent_no_of_ind_claims] => 47 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20050203025.pdf [firstpage_image] =>[orig_patent_app_number] => 11004107 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 32685 [patent_doc_number] => 07790682 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-09-07 [patent_title] => 'Engineered human acidic fibroblast growth factors and associated methods' [patent_app_type] => utility [patent_app_number] => 11/001804 [patent_app_country] => US [patent_app_date] => 2004-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9257 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/790/07790682.pdf [firstpage_image] =>[orig_patent_app_number] => 11001804 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5428114 [patent_doc_number] => 20090087424 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-02 [patent_title] => 'Modulating Retinal Pigmented Epithelium Permeaion By Inhibiting Or Activating VEGFR-1' [patent_app_type] => utility [patent_app_number] => 11/791759 [patent_app_country] => US [patent_app_date] => 2004-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11166 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20090087424.pdf [firstpage_image] =>[orig_patent_app_number] => 11791759 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 826649 [patent_doc_number] => 07402312 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-22 [patent_title] => 'Antibodies to vascular endothelial growth factor 2 (VEGF-2)' [patent_app_type] => utility [patent_app_number] => 10/992196 [patent_app_country] => US [patent_app_date] => 2004-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 69 [patent_no_of_words] => 122232 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 145 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/402/07402312.pdf [firstpage_image] =>[orig_patent_app_number] => 10992196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5041254 [patent_doc_number] => 20070093536 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-26 [patent_title] => 'Target protein of antidiabetic and novel antidiabetic insuful corresponding thereto' [patent_app_type] => utility [patent_app_number] => 10/569791 [patent_app_country] => US [patent_app_date] => 2004-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7704 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20070093536.pdf [firstpage_image] =>[orig_patent_app_number] => 10569791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 348954 [patent_doc_number] => 07495070 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-24 [patent_title] => 'Protein binding miniature proteins' [patent_app_type] => utility [patent_app_number] => 10/982727 [patent_app_country] => US [patent_app_date] => 2004-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 17 [patent_no_of_words] => 37425 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/495/07495070.pdf [firstpage_image] =>[orig_patent_app_number] => 10982727 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7127373 [patent_doc_number] => 20050059117 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'Vascular endothelial growth factor 2' [patent_app_type] => utility [patent_app_number] => 10/980815 [patent_app_country] => US [patent_app_date] => 2004-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 54 [patent_no_of_words] => 101478 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20050059117.pdf [firstpage_image] =>[orig_patent_app_number] => 10980815 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6952156 [patent_doc_number] => 20050227250 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-13 [patent_title] => 'Human Elk, a voltage-gated potassium channel subunit' [patent_app_type] => utility [patent_app_number] => 10/966297 [patent_app_country] => US [patent_app_date] => 2004-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 23193 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20050227250.pdf [firstpage_image] =>[orig_patent_app_number] => 10966297 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6925844 [patent_doc_number] => 20050239099 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-27 [patent_title] => '27 human secreted proteins' [patent_app_type] => utility [patent_app_number] => 10/963903 [patent_app_country] => US [patent_app_date] => 2004-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 134692 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20050239099.pdf [firstpage_image] =>[orig_patent_app_number] => 10963903 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7137976 [patent_doc_number] => 20050181995 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-18 [patent_title] => 'Venom-derived vascular endothelial growth factor-like protein having binding activity specific to vascular endothelial growth factor receptor type 2 and use thereof' [patent_app_type] => utility [patent_app_number] => 10/954311 [patent_app_country] => US [patent_app_date] => 2004-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12377 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20050181995.pdf [firstpage_image] =>[orig_patent_app_number] => 10954311 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 895356 [patent_doc_number] => 07341996 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-03-11 [patent_title] => 'Processed vascular endothelial growth factor-B polypeptides' [patent_app_type] => utility [patent_app_number] => 10/948736 [patent_app_country] => US [patent_app_date] => 2004-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 25 [patent_no_of_words] => 16243 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/341/07341996.pdf [firstpage_image] =>[orig_patent_app_number] => 10948736 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5904464 [patent_doc_number] => 20060046960 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-02 [patent_title] => 'Controlled and directed local delivery of anti-inflammatory compositions' [patent_app_type] => utility [patent_app_number] => 10/932878 [patent_app_country] => US [patent_app_date] => 2004-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7464 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20060046960.pdf [firstpage_image] =>[orig_patent_app_number] => 10932878 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7122411 [patent_doc_number] => 20050014240 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-20 [patent_title] => 'Aggregate-free protein compositions and methods of preparing same' [patent_app_type] => utility [patent_app_number] => 10/928370 [patent_app_country] => US [patent_app_date] => 2004-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6987 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20050014240.pdf [firstpage_image] =>[orig_patent_app_number] => 10928370 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5683492 [patent_doc_number] => 20060199762 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-07 [patent_title] => 'Skin ulcer preventive curative agent containing human recombinant hgf' [patent_app_type] => utility [patent_app_number] => 10/570046 [patent_app_country] => US [patent_app_date] => 2004-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10664 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0199/20060199762.pdf [firstpage_image] =>[orig_patent_app_number] => 10570046 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5051874 [patent_doc_number] => 20070032419 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'Fusion polypeptides, and use thereof in antivascular tumor therapy' [patent_app_type] => utility [patent_app_number] => 10/569076 [patent_app_country] => US [patent_app_date] => 2004-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 8979 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20070032419.pdf [firstpage_image] =>[orig_patent_app_number] => 10569076 [rel_patent_id] =>[rel_patent_doc_number] =>)